ERBB2 and breast cancer: However, among these cancer subtypes, triple negative (ER-, PR−, and HER2-) breast cancer without receptor sensitivity is the most lethal subtype due to its heterogeneity, aggressiveness, and lack of treatment options (Nedeljkovic and Damjanovic 2019).